Redermo Wound Matrix— 510(k) K260020

Name: FDA 510(k) clearance K260020
Creator: U.S. Food and Drug Administration
Published: 2026-04-16

Substantially Equivalent

Beijing Kreate Medical Co., Ltd.

FDA 510(k) clearance K260020 for Redermo Wound Matrix, Substantially Equivalent on 2026-04-16. Applicant: Beijing Kreate Medical Co., Ltd.. Device class: Unclassified.

Clearance details

Applicant: Beijing Kreate Medical Co., Ltd.
Product code: Code QSZ
Device class: Unclassified
Advisory panel: Unknown
Date received: 2026-01-05
Decision date: 2026-04-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beijing, CN

Download summary PDF View on FDA.gov ↗

Recent devices under product code QSZ

view all

K261311 — HYALOMATRIX2026-09-02
K254256 — LUOFUCON® Wound Matrix2026-08-18
K251567 — NovoSorb BTM2025-06-20
K242149 — NovoSorb® MTX2025-03-05
K241660 — SiOxD® Wound Matrix2024-07-05

More clearances from Beijing Kreate Medical Co., Ltd.

view all

K261646 — Redermax® Antibacterial Wound Matrix2026-08-14
K251582 — Redermax Antibacterial Wound Matrix2026-02-02

Data sourced from openFDA. This site is unofficial and independent of the FDA.